Analysis of FOXP4-AS1 expression, across 33 tumors from the TCGA and GTEx databases, revealed its upregulation in most tumors (Figure 1A), suggesting it potential as a poor prognostic factor in tumor patients. Here, FOXP4 is linked to neoplasm.